COMMUNIQUÉS West-GlobeNewswire

Sarepta Therapeutics Announces Second Quarter 2019 Financial Results and Recent Corporate Developments
07/08/2019
CAMBRIDGE, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the second quarter of 2019 [...]
TransMedics Reports Second Quarter 2019 Financial Results
07/08/2019
ANDOVER, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, [...]
Sunesis Pharmaceuticals Reports Second Quarter 2019 Financial Results and Recent Highlights
07/08/2019
Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the quarter [...]
Corvus Pharmaceuticals to Present at the 2019 Wedbush Healthcare Conference
07/08/2019
BURLINGAME, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Ovid Therapeutics Reports Second Quarter 2019 Financial Results and Highlights Recent Progress
07/08/2019
Phase 3 NEPTUNE Trial of OV101 in Angelman Syndrome on Track to Enroll the First Patients in the Third Quarter of 2019 Regulatory Authorities in the U.S. and Germany agree that NEPTUNE, if positive, could support the [...]
CohBar Reports Second Quarter 2019 Financial Results and Business Update
07/08/2019
Company to host conference call and webcast today, August 7 th , at 5:00 p.m. EDT MENLO PARK, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing [...]
Athersys Reports Second Quarter 2019 Results
07/08/2019
Management to host conference call at 4:30 pm EDT today CLEVELAND, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended June 30, 2019. [...]
Foamix Reports Second Quarter 2019 Financial Results and Provides Corporate Update
07/08/2019
Conference Call Scheduled for Thursday, August 8th at 8:30am Eastern Time REHOVOT, Israel, and BRIDGEWATER, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company [...]
Wright Medical Group N.V. Reports 2019 Second Quarter Financial Results
07/08/2019
Second Quarter 2019 Net Sales, Including Cartiva®, of $230 Million, Representing As-Reported Growth of 12%, Constant Currency Growth of 13% and Organic Constant Currency Growth of 9% Second Quarter 2019 Net Loss From [...]
Clearside Biomedical Announces Second Quarter 2019 Financial Results and Provides Corporate Update
07/08/2019
- Strategic Focus on Building Internal Pipeline and External Collaborations Based on Suprachoroidal Space Injection Platform - - Clearside Plans to Out-License XIPERE ™ - - Management to Host Webcast and Conference Call [...]
OPKO Health Reports 2019 Second Quarter Business Highlights and Financial Results
07/08/2019
Conference call begins today at 4:30 p.m. Eastern time MIAMI, Aug. 07, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended June 30, 2019 [...]
Novavax Reports Second Quarter 2019 Financial Results
07/08/2019
Agreement with the FDA on Phase 3 non-inferiority immunogenicity study design for NanoFlu™ NanoFlu pivotal Phase 3 clinical trial expected to initiate in the third quarter of 2019 with top-line data in the first quarter [...]
TG Therapeutics to Host Conference Call on Second Quarter 2019 Financial Results and Business Update
07/08/2019
Conference Call to be held Friday, August 9, 2019 at 8:30 AM ET NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Friday, August 9, [...]
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019
07/08/2019
Reports Net Revenues of $79.0 Million for the Three Months Ended June 30, 2019 RANCHO CUCAMONGA, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) [...]
MyoKardia Reports Second Quarter 2019 Financial Results
07/08/2019
Announces Last Patient to be Enrolled in EXPLORER-HCM Phase 3 during the Week of August 12 th ; Topline Data Accelerated to 2 nd Quarter 2020 Topline Phase 2 Clinical Data from MAVERICK-HCM and MYK-491 on Track for [...]
Assertio Therapeutics Announces Strong Second-Quarter 2019 Results
07/08/2019
-- Reports Total Company GAAP Net Sales of $57.2 million, Total Company Non-GAAP Net Sales of $59.3 million, including Commercialization Agreement Revenues of $31.0 million -- -- Drives Continued Improvement in [...]
Tauriga Sciences Inc. Launches Strategic Initiatives to Increase its E-Commerce Revenue as Well as Tauri-Gum Brand Visibility
07/08/2019
New York, NY, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Retrotope Announces Full Enrollment of Phase 2/3 trial in patients with Infantile Neuroaxonal Dystrophy (INAD)
07/08/2019
Study expected to read out by Q3, 2020 LOS ALTOS, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Retrotope announced today that it has fully enrolled all patients in the first clinical trial of a possible treatment for [...]
BioAegis Therapeutics Reports Favorable Safety and Pharmacokinetic Results in its Phase 1b/2a Dose-Escalation Study of Recombinant Human Plasma Gelsolin with Highest Doses Ever Administered to Patients
07/08/2019
MORRISTOWN, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc. announced the major findings from its Phase 1b/2a study of Recombinant Human Plasma Gelsolin for patients requiring hospitalization because [...]

Pages